The potential of NORAD­PUMILIO­RALGAPB regulatory axis as a biomarker in breast cancer

Muller, Cristiane Sato Mara; Giner, Igor Samesima; Zambalde, Érika Pereira; Carvalho, Tamyres Mingorance; Ribeiro, Enilze Maria de Souza Fonseca; Oliveira, Jaqueline Carvalho de; Mathias, Carolina; Gradia, Daniela Fiori.
Artículo en Portugués | ARCA | ID: arc-56445

Documentos relacionados

  1. Looking for a job in a dynamic and collaborative working place? LncRNAs are recruiting!
  2. Long non-coding RNA ARHGAP5-AS1 inhibits migration of breast cancer cell via stabilizing SMAD7 protein.
  3. Placing non-coding RNAs in the Central Dogma: An interview with Ling-Ling Chen.
  4. The contribution of databases towards understanding the universe of long non-coding RNAs.
  5. A novel LncRNA PTH-AS upregulates interferon-related DNA damage resistance signature genes and promotes metastasis in human breast cancer xenografts.
  6. XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivation.
  7. Thirteen dubious ways to detect conserved structural RNAs.
  8. From structure to function: Route to understanding lncRNA mechanism.
  9. A "Counter-Enhancer" in Tumor Suppression.
  10. Integrated lncRNA function upon genomic and epigenomic regulation.